According to UnitedHealth's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.8879. At the end of 2022 the company had a P/E ratio of 24.7.
Year | P/E ratio | Change |
---|---|---|
2022 | 24.7 | -9.96% |
2021 | 27.4 | 26.87% |
2020 | 21.6 | 6.99% |
2019 | 20.2 | 0.99% |
2018 | 20.0 | -0.64% |
2017 | 20.1 | -4.41% |
2016 | 21.1 | 9.16% |
2015 | 19.3 | 10.55% |
2014 | 17.5 | 29.65% |
2013 | 13.5 | 33.53% |
2012 | 10.1 | -4.53% |
2011 | 10.6 | 21.34% |
2010 | 8.70 | -6.65% |
2009 | 9.32 | -14.5% |
2008 | 10.9 | -33.32% |
2007 | 16.3 | -5.98% |
2006 | 17.4 | -31.72% |
2005 | 25.5 | 11.67% |
2004 | 22.8 | 9.76% |
2003 | 20.8 | 10.74% |
2002 | 18.8 | -22.58% |
2001 | 24.2 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | 18.7 | 4.48% | ๐บ๐ธ USA |
![]() | 10.9 | -39.23% | ๐บ๐ธ USA |
![]() | 12.9 | -28.11% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.